API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

China API Anticoagulants Apixaban Purity Apixaban Powder Apixaban, Find details about China Apixaban, Intermediate Apixaban from API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

Basic Info.

Model NO.

Condavo-Apixaban

Name

Apixaban

Product Name

Apixaban Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

503612-47-3

C25h25n5o4

459.506

Density

1.42

Boiling Point

770.468c at 760 Mmhg

Refractive Index

1.705

Flash Point

419.764c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Apixaban

Name

Apixaban

Product Name

Apixaban Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

CAS

503612-47-3

C25h25n5o4

459.506

Density

1.42

Boiling Point

770.468c at 760 Mmhg

Refractive Index

1.705

Flash Point

419.764c

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

Product Name	Apixaban
CAS	503612-47-3
Appearance	White crystalline powder
MF	C25H25N5O4
MW	459.506
Purity	99%
Shelf Life	2 Years

Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. It is used as an alternative to wa rfarin and does not require monitoring by blood tests or dietary restrictions. It is taken by mouth.

API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

API Anticoagulants Apixaban Purity Apixaban Powder Apixaban Apixaban was approved for medical use in the European Union in May 2011, and in the United States in December 2012. In 2018, it was the 66th most commonly prescribed medication in the United States with more than 12 million prescriptions. In December 2019, generic versions were approved in the United States.
API Anticoagulants Apixaban Purity Apixaban Powder Apixaban

1.Apixaban is factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke.
2.Apixaban also have effect i systemic in patients with nonvavular atrial fibrillation.

API Anticoagulants Apixaban Purity Apixaban Powder Apixaban